Daring imagination in biotech
CONTACT US

Our company

Leading-edge science

Our proprietary and innovative approach to mAbs' engineering opens new frontiers to biotech industry development

Strong experience

Our Leadership Team has a cumulative experience of 40+ years in Global Healthcare

Solid partnerships

We work with a number of world-class scientific and operational partners to materialize our vision

Business Potential

We aim to become a world-class R&D biotech company by 2030, worth between 25-30 billion USD

Our Vision

We are an early-stage biotech company dedicated to developing innovative treatments for high-impact autoimmune diseases like Rheumatoid Arthritis, Psoriathic arthritis, Psoriasis, Chron's disease.

After 10 years of pioneering in-house research, we have developed a breakthrough cell synthesis platform (MSYNC) and a candidate drug (MBN-1).

MSYNC and MBN-1 promise to be the foundation for a completely new generation of mAbs, whose pharmacological characteristics are expected to solve many of the drawbacks of currently available biological therapies.
PARTNERSHIP OPPORTUNITIES

Contact us

Mabionics Ltd.
North Point Business Park
New Mallow Road
Cork - IRELAND

Contattaci

I hereby consent that my personal information is stored and treated by Mabionics Ltd. according to GDPR rule.